TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
5.55
+0.16 (2.97%)
At close: Oct 14, 2024, 4:00 PM
5.53
-0.02 (-0.36%)
After-hours: Oct 14, 2024, 4:23 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $294.00 million as of October 14, 2024. Its market cap has increased by 134.64% in one year.
Market Cap
294.00M
Enterprise Value
87.40M
1-Year Change
134.64%
Ranking
Category
Stock Price
$5.55
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $294.00M, a decrease of -18.12%. That is a compound annual growth rate of -5.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 285.50M | 2.40% |
| Dec 29, 2023 | 278.80M | 647.45% |
| Dec 30, 2022 | 37.30M | -65.14% |
| Dec 31, 2021 | 107.00M | -70.20% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 293.79M |
| Alpha Teknova | 290.50M |
| Sight Sciences | 288.76M |
| Sanara MedTech | 288.21M |
| PepGen | 287.12M |
| Ocugen | 283.54M |
| Design Therapeutics | 283.10M |
| Heron Therapeutics | 279.07M |